Status:

COMPLETED

Acetaminophen for Oxidative Stress After Cardiopulmonary Bypass

Lead Sponsor:

Vanderbilt University Medical Center

Conditions:

Congenital Heart Disease

Cardiopulmonary Bypass

Eligibility:

All Genders

1-17 years

Phase:

NA

Brief Summary

The current proposal tests the central hypothesis that acetaminophen will attenuate the oxidative stress response associated with cardiopulmonary bypass (CPB)-induced hemolysis in children undergoing ...

Detailed Description

Infants with complex congenital cardiac defects frequently undergo cardiopulmonary bypass (CBP) during surgical repair of their cardiac lesions (1). CBP exposes infants and children to endothelial dam...

Eligibility Criteria

Inclusion

  • Patients will be eligible for enrollment based on the following inclusion criteria:
  • 1\) Infants or children (newborn to 17years of age) undergoing cardiopulmonary bypass for biventricular surgical correction of their congenital heart lesions.
  • Patients will not be eligible for this study based on the following exclusion criteria:
  • Patients scheduled for single ventricle palliation will be excluded, in an effort to standardize the time of repair, time on CPB, and surgical procedure.
  • Patients with severe neurological abnormalities at baseline.
  • Patients with major non-cardiac congenital malformations, developmental disorders or serious chronic disorders. Benign congenital malformations (such as club foot, ear tags, etc.) will not exclude the subject from the study.
  • Non-English speaking patients, or parent/legal guardians.
  • Patients less than 3 kg, to limit risk of excessive blood loss from lab draws.
  • Previous adverse reaction to acetaminophen
  • History of acute or chronic kidney disease
  • History of chronic liver disease
  • Emergency surgery

Exclusion

    Key Trial Info

    Start Date :

    July 1 2011

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    March 1 2014

    Estimated Enrollment :

    30 Patients enrolled

    Trial Details

    Trial ID

    NCT01228305

    Start Date

    July 1 2011

    End Date

    March 1 2014

    Last Update

    April 21 2017

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Vanderbilt University

    Nashville, Tennessee, United States, 37232